TAKARA BIO INC. Board Supports Tender

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 16, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

TAKARA BIO INC. Board Supports Tender Offer, Recommends Shareholders Tender

Source disclosure: February 16, 2026 TAKARA BIO INC. [4974.T] TOKYO — Takara Bio Inc., represented by President and CEO Tsuyoshi Miyamura, has issued an announcement regarding corrections to its board's recommendation supporting a tender offer from parent company Tomy Holdings Co. Ltd. The corrections were made following a review of the supplementary documents attached to the statement released on February 12, 2026. The special committee of Takara Bio submitted a report to the compa